The potential of cannabis in the fight against melanoma: a new hope in skin cancer treatment

Skin cancer is one of the most common malignant forms diagnosed globally, presenting a significant challenge for contemporary medicine. Traditional therapies often fail to achieve desired levels of efficacy due to drug resistance. However, a new hope emerges in the form of an innovative approach that combines nanotechnology and cannabidiol (CBD), derived from cannabis, to combat this type of cancer.

Nanoparticles: revolutionizing skin cancer therapy 

To overcome the limitations of conventional therapies, scientists have been exploring nanoparticles as next-generation vehicles for better interaction with cancer cells. A recent study developed a combined therapy using a nanostructured lipid carrier gel loaded with 5-fluorouracil (5-FU) and cannabidiol (CBD), known as FU-CBD-NLCs gel. This research aimed to evaluate the safety and efficacy of this innovative formulation in skin cancer treatment.

Efficient absorption and less irritation 

Initial results were promising. Confocal microscopy revealed excellent absorption and deposition of the formulation in the epidermal and dermal layers of the skin. Irritation tests conducted with infrared cameras and HET cameras showed that NLCs FU-CBD were much more tolerable and less irritating compared to conventional treatments.

Skin retention and tumor reduction 

Furthermore, gamma scintigraphy (special detector to create an image after the injection of radioactive material) highlighted the retention behavior of the formulation in the skin, indicating greater permanence and efficient absorption. Tumor remission studies revealed that NLCs FU-CBD were able to significantly reduce tumor volume compared to conventional formulations. This points to a higher efficacy in skin cancer treatment.

A promising carrier for the future 

The results obtained indicate that the permeation and disposition of 5-FU and CBD in different skin layers through the NLCs FU-CBD gel have the potential to be a more effective carrier than conventional gels. Additionally, the prepared formulation showed notable tumor remission, improved survival rate, and reduction in the number, area, and volume of the tumor, accompanied by a favorable biochemical profile.

Therefore, the NLCs FU-CBD gel represents a promising approach for non-melanoma skin cancer treatment. The combination of nanotechnology and cannabidiol offers a new hope in the fight against this devastating disease, potentially providing a more effective and less invasive therapy for patients. Research continues to advance in this field, bringing light to the future of melanoma treatment.